Sunshine Biopharma (SBFM) Non Operating Interest Expenses (2012 - 2024)
Sunshine Biopharma (SBFM) recorded Non Operating Interest Expenses of $8,529 in Q4 2024, down 71.7% from $30,110 a year earlier.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Non Operating Interest Expenses (2012 - 2024) Analysis & Trends
For FY2024, Sunshine Biopharma reported Non Operating Interest Expenses of $8,774, down 93.6% from FY2023.
- Annual Non Operating Interest Expenses has a five-year compound annual growth rate of -40.3% (FY2019 to FY2024).
- Across earlier years, Non Operating Interest Expenses came in at $137,308 in FY2023 (+248.4%), $39,412 in FY2022 (-88.0%), $328,818 in FY2021 (+95.6%) and $168,105 in FY2020 (+45.0%).
- Quarterly Non Operating Interest Expenses has ranged from $2.00 in Q3 2022 to $195,630 in Q2 2021 over the past five years.
- On a year-over-year basis, Non Operating Interest Expenses rose in three of the last five quarters, with growth averaging 17.6%.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 707.8% in Q2 2021, against a decline of 100.0% in Q3 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Sunshine Biopharma | 1.05 Mn | -38.04 Mn | 2.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 8,529.00 |
| Jun 30, 2024 | 245.00 |
| Mar 31, 2024 | 49,181.00 |
| Dec 31, 2023 | 30,110.00 |
| Sep 30, 2023 | 38,527.00 |
| Jun 30, 2023 | 3,331.00 |
| Mar 31, 2023 | 41,075.00 |
| Dec 31, 2022 | 26,546.00 |
| Sep 30, 2022 | 2.00 |
| Mar 31, 2022 | 12,864.00 |
| Dec 31, 2021 | 36,630.00 |
| Sep 30, 2021 | 46,849.00 |
| Jun 30, 2021 | 195,630.00 |
| Mar 31, 2021 | 49,711.00 |
| Dec 31, 2020 | 105,436.00 |
| Sep 30, 2020 | 22,094.00 |
| Jun 30, 2020 | 24,219.00 |
| Mar 31, 2020 | 16,356.00 |
| Dec 31, 2019 | 23,415.00 |
| Sep 30, 2019 | 27,847.00 |
API Access
Sunshine Biopharma Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SBFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "SBFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=SBFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();